InvestorsHub Logo
Followers 19
Posts 3136
Boards Moderated 0
Alias Born 01/12/2009

Re: None

Wednesday, 08/12/2009 8:27:28 AM

Wednesday, August 12, 2009 8:27:28 AM

Post# of 30806
(Wed Aug. 12) avVaa World Health Care Products, Inc. DRTV Campaign for Neuroskin(R) Psoriasis Relief Is on Schedule for August Launch

LUMBY, BC, Aug 12, 2009 (MARKETWIRE via COMTEX) -- avVaa World Health Care Products Inc. (PINKSHEETS: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, is pleased to announce that the DRTV campaign is on schedule for the August media test.

avVaa President & COO Lorie Campbell-Farley says, "We are very impressed with our DRTV spot, and we expect to launch it the week of August 24th, 2009."

Neuroskin(R) will gain consumer confidence with back to back media repetition campaigns. This will generate consumer confidence, and an urgency to buy. Neuroskin(R) fills the consumer gap for a steroid-free solution for psoriasis, seborrheic dermatitis, acne and other skin irritations. It is doctor recommended, but no prescription is required.

avVaa World Health Care is making things happen by creating a marketing buzz with Direct Response TV marketing, using a world-class media company. The first of six product launches, Neuroskin(R) targets consumers suffering from Psoriasis, acne or other skin ailments who haven't been able to find long-term relief with out toxic side-effects.

Relief has arrived.....

Improving quality of life and well-being for humans and domestic animals......naturally.....

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.

Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

CONTACT:

avVaa World Health Care Products

Jack Farley
Chairman/CEO/Founder
jfarley@avvaa.com

Lorie Campbell-Farley
President/COO/Co Founder
lcfarley@avvaa.com

Investor Relations:
Merle Goertz (West Coast)
1-604-688-2349



SOURCE: avVaa World Health Care Products, Inc.